Closely observe for at least 15 min following vaccination & appropriate medical treatment & supervision should be ready in case of anaphylactic event. Do not administer intravascularly or intradermally. Postpone vaccination in individuals suffering from acute severe febrile illness. Caution in individuals w/ thrombocytopenia or any coagulation disorder following IM administration. Patients receiving immunosuppressive treatment or those w/ immunodeficiency may have reduced immune response to Arexvy. Minor influence on ability to drive & use machines. Not recommended during pregnancy & in breast-feeding/lactating women. Childn.
May be administered concomitantly w/ seasonal flu vaccine (quadrivalent, standard dose, unadjuvanted, inactivated). Always administer at different inj sites if to be given at the same time as another injectable vaccine.
J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.
Sign Out
38b9a396-ae12-4b60-90ef-b288010270d7.GIF)
